Recent studies have also investigated the potential of radiomics features in predicting other molecular markers for glioma, such as isocitrate dehydrogenase (IDH) mutation (11), O6-methylguanine-DNA-methyltransferase (MGMT) methylation status (12), and molecular subgroups (13, 14). This evidence concerns the gene MGMT and glioma.